Pediatric Obesity
3 articles on Pediatric Obesity, written by Shotlee and medically reviewed for clinical accuracy.
Wegovy for Children: Safety Concerns, Obesity Trends, and Expert Advice
An in-depth look at the controversial use of GLP-1 medications in pediatric patients, childhood obesity statistics, and long-term safety concerns highlighted by medical experts.
8 min read
Novo Nordisk Expands Ozempic, Wegovy Testing on Adolescents
Novo Nordisk, maker of Ozempic and Wegovy, has launched a three-year research partnership to test weight-loss GLP-1 drugs on adolescents in Pacific Island nations, beginning in Fiji. Announced amid a Danish royal visit, this move addresses the obesity 'ticking bomb' threatening kids' lifespans. CEO Mike Doustdar urges bolder action on prevention and access.
5 min read
Wegovy Funding in NZ: Case for Teens with Severe Obesity
New Zealand's Pharmac advisory panel has recommended funding Wegovy for chronic weight management in those with high BMI and related conditions. Paediatric endocrinologist Professor Wayne Cutfield argues strongly for including obese teens to prevent lifelong health crises. This guide breaks down the science, evidence, and implications.
5 min read